Skip to content
10-Q

Quarterly Report

QUANTRX BIOMEDICAL CORPORATION

0001654954-20-012604

← back to feed
Filed
Nov 17, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 16, 2020 78.7M sh
Cash And Equivalents Q3 2020 · Sep 30, 2020 $61.27K
Cash And Equivalents Q3 2020 · Dec 31, 2019 $130.35K
Cash And Equivalents Q3 2020 · Sep 30, 2019 $154.96K
Cash And Equivalents Q3 2020 · Dec 31, 2018 $322.02K
Total Liabilities Q3 2020 · Sep 30, 2020 $2.38M
Total Liabilities Q3 2020 · Dec 31, 2019 $2.27M
Current Assets Q3 2020 · Sep 30, 2020 $61.27K
Current Assets Q3 2020 · Dec 31, 2019 $137.35K
Total Assets Q3 2020 · Sep 30, 2020 $61.27K
Total Assets Q3 2020 · Dec 31, 2019 $137.35K
Revenue Q3 2020 · Sep 30, 2020 $0
Revenue Q3 2020 · Sep 30, 2020 $0
Revenue Q3 2020 · Sep 30, 2019 $0
Revenue Q3 2020 · Sep 30, 2019 $0
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$167.06K
Stockholders Equity Q3 2020 · Sep 30, 2019 −$1.82M
Stockholders Equity Q3 2020 · Jun 30, 2019 −$1.72M
Stockholders Equity Q3 2020 · Dec 31, 2018 −$1.51M
Sga Expense Q3 2020 · Sep 30, 2019 $16.3K
Sga Expense Q3 2020 · Sep 30, 2019 $55.67K
Net Income Q3 2020 · Sep 30, 2019 −$99.73K
Net Income Q3 2020 · Sep 30, 2019 −$309.43K
Operating Income Q3 2020 · Sep 30, 2019 −$44.88K
Operating Income Q3 2020 · Sep 30, 2019 −$165.72K